CRT 2017 : FDA Town Hall - Evaluating DES for High-Risk DAPT Patients

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

FDA Town Hall - Evaluating DES for High-Risk DAPT Patients

Featuring

  • Michael John
  • Davide Capodanno
  • Hans-Peter Stoll

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Adjunctive DAPT Labeling for DES – An FDA View - Michael John
Short versus Long DAPT Studies – An Academic View - Davide Capodanno
Study Designs of Short DAPT in the USA – Challenges and Execution of Pivotal Trials - Hans-Peter Stoll

Target Audience

Learning Objectives

Related Moments

Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives
Journal
Article on Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives
CRT 2016 Valve & Structural - The Mitraclip Workshop - Show Me the Data
Conference
Mitraclip Workshop at CRT 2016 (Sponsored by Abbott Vascular)
Supported By
CRT 2017 : COMPLEX CORONARY INTERVENTIONS - PCI 2017: Expanding the Boundaries Left Main & Multivessel Intervention
Conference
Loading Simple Education